drugset / Trial / NCT00637130

Safety and Intraocular Pressure (IOP) Lowering Efficacy of Low Dose Travoprost

NCT00637130

Phase 2 Completed 138 enrolled Alcon Research
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to compare the safety and IOP-lowering efficacy of various low dose travoprost formulations in patients with open-angle glaucoma or ocular hypertension.

Timeline

Start
2007-10
Primary completion
2008-01
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Travoprost Other / unclassified 0.0008 % Other
Subject Travoprost Other / unclassified 0.001 % Other
Subject Travoprost Other / unclassified 0.0012 % Other